BIONET Corp. (TPEX:1784)
85.40
-0.10 (-0.12%)
Apr 2, 2025, 1:30 PM CST
BIONET Revenue
In the year 2024, BIONET had annual revenue of 1.22B TWD with 8.40% growth. BIONET had revenue of 328.86M in the quarter ending December 31, 2024, with 15.57% growth.
Revenue
1.22B
Revenue Growth
+8.40%
P/S Ratio
3.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.22B | 94.73M | 8.40% |
Dec 31, 2023 | 1.13B | 146.93M | 14.99% |
Dec 31, 2022 | 980.38M | 58.96M | 6.40% |
Dec 31, 2021 | 921.42M | 114.85M | 14.24% |
Dec 31, 2020 | 806.58M | 31.02M | 4.00% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Center Laboratories | 1.62B |